Similar Items: Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa
- Conflicted cure: explorting concepts of default and adherence in drug resistant tuberculosis patients in Khayelitsha
- The incidence of tuberculosis in adolescents in the context of proposed TB vaccine trials
- Incidence of aminoglycoside-induced hearing loss in HIV positive and HIV negative multidrug-resistant tuberculosis patients
- Immunoproteome of anti-TB drug associated DRESS in HIV TB co-infection
- Disease dynamics in patients with drug-resistant tuberculosis residing in a high incidence community
- Mechanisms of resistance to new generation anti-TB drugs
Author: Cox, Helen
- Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa
- The Epidemiology and Evolution of Rifampicin Mono Resistant Tuberculosis in Khayelitsha, Cape Town, South Africa
- Rifampicin-resistant tuberculosis in Botswana: barriers and risk factors influencing patient outcomes, case detection, and linkage to effective care and treatment